Search

Displaying results 7641 - 7650 of 8696 in total
  1. Drug

    Picolinic acid

    go.drugbank.com/drugs/DB05483
    Experimental

    It acts as an anti-infective and immunomodulator and is produced in approximately 25-50 mg quantities by the body on a daily basis through the breakdown of tryptophan. … Picolinic acid has been shown to be an anti-viral in vitro and in vivo, and sometimes works in conjunction with other cytokines such as interferon gamma to affect immune responses.

  2. Drug

    Mirococept

    go.drugbank.com/drugs/DB06492
    Experimental

    Mirococept (APT070) is a complement inhibitor currently under development for treatment of rheumatoid arthritis and I/RI. … It is a truncated form of the human Complement Receptor 1 (CR1) linked to a unique Prodaptin™ construct that regulates the over-production of complement at the cell surface, which occurs in inflammation

  3. Drug

    Vercirnon

    go.drugbank.com/drugs/DB15250
    Investigational

    Vercirnon is a novel, orally active anti-inflammatory agent that targets a chemokine receptor protein implicated in both Crohn's disease and ulcerative colitis, the two principal forms of IBD.

  4. Drug

    AGS-16C3F

    go.drugbank.com/drugs/DB17551
    Investigational

    AGS 16C3F is an intravenously administered, anti-ectonucleotide pyrophosphatase/phosphodiesterase 3 (ENPP3) antibody-drug conjugate.

  5. Drug

    Tretoquinol

    go.drugbank.com/drugs/DB13692
    Investigational

    Categories: Adrenergics for Systemic Use, Drugs for Obstructive Airway Diseases
  6. Target

    Calcium-activated potassium channel subunit beta-2

    go.drugbank.com/bio_entities/BE0003196
    TargetHumans

    May participate in KCNMA1 inactivation in chromaffin cells of the adrenal gland or in hippocampal CA1 neurons

    Synonyms: Charybdotoxin receptor subunit beta-2
  7. Drug

    CMLVAX100

    go.drugbank.com/drugs/DB05164
    Experimental

    CMLVAX100 is a vaccine targeting the BCR-ABL-derived p210 fusion protein which reduces residual disease in some patients with chronic myeloid leukemia. It is developed by Breakthrough Therapeutics and has completed phase I of its clinica...

  8. Drug

    Thyrotropin

    go.drugbank.com/drugs/DB15263
    Investigational

    Thyrotropin is under investigation in clinical trial NCT01348191 (Detection of Thyrotrophin Receptor in Human Myometrium).

    Categories: Tests for Thyreoidea Function
  9. Drug

    Oxiracetam

    go.drugbank.com/drugs/DB13601
    Investigational

    Categories: Psychostimulants, Agents Used for ADHD and Nootropics
  10. Drug

    Indantadol

    go.drugbank.com/drugs/DB12664
    Investigational

    Indantadol has been used in trials studying the treatment of Cough and Diabetic Peripheral Neuropathic Pain.

    Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates